Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Zione** is a non-specific Indian antihypertensive brand designation rather than a single chemical entity. The base Zione 6.25 mg tablet contains **chlorthalidone**, a thiazide-like diuretic used for hypertension and edema. Closely named products under the Zione brand family include fixed-dose combinations of chlorthalidone with an angiotensin II type 1 receptor blocker: losartan in Zione DSL, telmisartan in Zione DS T, and olmesartan medoxomil in Zione O. These products lower blood pressure through renal sodium and water excretion and, in combination products, blockade of angiotensin II-mediated vasoconstriction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ZIONE.